{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:55:26Z","timestamp":1790891726935,"version":"4.1.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009857","name":"Regeneron Pharmaceuticals Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi US","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaadinternational.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD International"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jdin.2026.04.025","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T16:35:27Z","timestamp":1781886927000},"page":"25-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Healthcare resource utilization and costs in pediatric patients under 6 years old with atopic dermatitis in the United States: A retrospective, observational, cross-sectional study"],"prefix":"10.1016","volume":"28","author":[{"given":"Jonathan I.","family":"Silverberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengtian","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry","family":"Noonan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Korotzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jdin.2026.04.025_bib1","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/pai.12095","article-title":"Association between severe eczema in children and multiple comorbid conditions and increased healthcare utilization","volume":"24","author":"Silverberg","year":"2013","journal-title":"Pediatr Allergy Immunol"},{"issue":"2","key":"10.1016\/j.jdin.2026.04.025_bib2","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3122\/jabfm.2019.02.180225","article-title":"The burden of childhood atopic dermatitis in the primary care setting: a report from the Meta-LARC Consortium","volume":"32","author":"Al-Naqeeb","year":"2019","journal-title":"J Am Board Fam Med"},{"issue":"4","key":"10.1016\/j.jdin.2026.04.025_bib3","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.anai.2020.12.020","article-title":"Atopic dermatitis in the pediatric population: a cross-sectional, international, epidemiologic study","volume":"126","author":"Silverberg","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"3","key":"10.1016\/j.jdin.2026.04.025_bib4","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.anai.2023.11.009","article-title":"Atopic dermatitis (eczema) guidelines: 2023 American Academy of Allergy, Asthma and Immunology\/American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters GRADE- and Institute of Medicine-based recommendations","volume":"132","author":"Chu","year":"2024","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"10.1016\/j.jdin.2026.04.025_bib6","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/jdv.16928","article-title":"A phase 2, open-label study of single-dose dupilumab in children aged 6 months to <6 years with severe uncontrolled atopic dermatitis: pharmacokinetics, safety and efficacy","volume":"35","author":"Paller","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.jdin.2026.04.025_bib7","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s40257-024-00859-y","article-title":"Dupilumab safety and efficacy up to 1 year in children aged 6 months to 5 years with atopic dermatitis: results from a phase 3 open-label extension study","volume":"25","author":"Paller","year":"2024","journal-title":"Am J Clin Dermatol"},{"issue":"1","key":"10.1016\/j.jdin.2026.04.025_bib8","doi-asserted-by":"crossref","DOI":"10.1080\/09546634.2024.2411834","article-title":"Longer-term safety and efficacy of baricitinib for atopic dermatitis in pediatric patients 2 to <18 years old: a randomized clinical trial of extended treatment to 3.6 years","volume":"35","author":"Wollenberg","year":"2024","journal-title":"J Dermatolog Treat"},{"issue":"3","key":"10.1016\/j.jdin.2026.04.025_bib10","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.jaad.2019.07.105","article-title":"Treatment patterns of pediatric patients with atopic dermatitis: a claims data analysis","volume":"82","author":"Paller","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jdin.2026.04.025_bib11","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2165\/00003495-200969030-00005","article-title":"Systemic therapy of atopic dermatitis in children","volume":"69","author":"Ricci","year":"2009","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.jdin.2026.04.025_bib12","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jaad.2014.03.030","article-title":"Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents","volume":"71","author":"Sidbury","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jdin.2026.04.025_bib13","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.clindermatol.2014.12.005","article-title":"Systemic therapy of childhood atopic dermatitis","volume":"33","author":"Slater","year":"2015","journal-title":"Clin Dermatol"},{"issue":"1","key":"10.1016\/j.jdin.2026.04.025_bib14","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jaci.2018.11.006","article-title":"The atopic march and atopic multimorbidity: many trajectories, many pathways","volume":"143","author":"Paller","year":"2019","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.jdin.2026.04.025_bib15","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/jvc2.74","article-title":"Societal economic burden and determinants of costs for atopic dermatitis","volume":"1","author":"Orts\u00e4ter","year":"2022","journal-title":"JEADV Clin Pract"},{"issue":"2","key":"10.1016\/j.jdin.2026.04.025_bib16","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2022-060531","article-title":"Patterns in the development of pediatric allergy","volume":"152","author":"Gabryszewski","year":"2023","journal-title":"Pediatrics"},{"key":"10.1016\/j.jdin.2026.04.025_bib17","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s40124-024-00321-x","article-title":"Use of dupilumab in pediatric patients: a review","volume":"12","author":"Bauer","year":"2024","journal-title":"Curr Pediatr Rep"},{"issue":"5","key":"10.1016\/j.jdin.2026.04.025_bib18","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.pedhc.2006.04.009","article-title":"Atopic dermatitis in Italian children: evaluation of its economic impact","volume":"20","author":"Ricci","year":"2006","journal-title":"J Pediatr Health Care"},{"issue":"9","key":"10.1016\/j.jdin.2026.04.025_bib19","doi-asserted-by":"crossref","first-page":"762","DOI":"10.2340\/00015555-3212","article-title":"Economic burden of adult patients with moderate to severe atopic dermatitis indicated for systemic treatment","volume":"99","author":"Ari\u00ebns","year":"2019","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"10.1016\/j.jdin.2026.04.025_bib20","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1080\/13696998.2022.2152234","article-title":"The humanistic and economic burden of atopic dermatitis among adults and adolescents in Saudi Arabia","volume":"25","author":"Elezbawy","year":"2022","journal-title":"J Med Econ"},{"issue":"1","key":"10.1016\/j.jdin.2026.04.025_bib21","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s13555-022-00857-0","article-title":"Humanistic and economic burden of atopic dermatitis for adults and adolescents in the Middle East and Africa region","volume":"13","author":"Elezbawy","year":"2023","journal-title":"Dermatol Ther (Heidelb)"},{"key":"10.1016\/j.jdin.2026.04.025_bib22","doi-asserted-by":"crossref","DOI":"10.2340\/actadv.v103.4842","article-title":"Economic and humanistic burden in paediatric patients with atopic dermatitis","volume":"103","author":"Achten","year":"2023","journal-title":"Acta Derm Venereol"}],"updated-by":[{"DOI":"10.1016\/j.jdin.2026.08.002","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000}},{"DOI":"10.1016\/j.jdin.2026.08.002","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000}}],"container-title":["JAAD International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666328726001112?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666328726001112?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:00:48Z","timestamp":1790888448000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666328726001112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":20,"alternative-id":["S2666328726001112"],"URL":"https:\/\/doi.org\/10.1016\/j.jdin.2026.04.025","relation":{},"ISSN":["2666-3287"],"issn-type":[{"value":"2666-3287","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Healthcare resource utilization and costs in pediatric patients under 6 years old with atopic dermatitis in the United States: A retrospective, observational, cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"JAAD International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdin.2026.04.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}